Digg icon reddit icon Stumbleupon icon
Print Email     Print Edition Stories
Randolph Noelle, a co-founder of ImmuRx, works in his lab at Dartmouth Medical School.

Thursday, June 18, 2009

Cancer vaccine developer ImmuRx lands $250K in seed funding

By MHT Staff

ImmuRx Inc., a Lebanon, N.H.-based vaccine developer for cancer and chronic infections, has pulled in $250,000 in seed funding from Allyon Capital Partners LLC, a subsidiary of Allyon Solutions, an investment firm in Hanover, N.H.

The investment brings additional funding to the $329,000 SBIR grant from the National Institutes of Health that ImmuRx received in April. The SBIR grant will apply to further development of the company’s hCD40 compound, intended to strengthen vaccines in treating metastatic melanoma. While the company is working on fighting melanoma, applications could be broad, with potential to target cancer stem cells, bacterial or viral infections, and HIV/AIDS viruses, according to CEO David DeLucia.

The immune system is composed of an ancient line of “innate” defenses conserved from the distant past, and an “acquired” set of selective defenses that can generate billions of permutations to fight a pathogen. ImmuRx’s vaccine candidate is intended to activate both parts of the system.

Last November, the vaccine developer said that it was seeking $250,000 of angel seed money as a prelude to an $8 million Series A round of investment that it intends to apply to clinical trials of a new cancer vaccine. At the time, ImmuRx officials said it planned on the Series A round for the first quarter of 2009, but the company has not yet begun an investment round.

Allyon invests in firms that have some startup capital for its patented technology. Allyon Solutions also consists of two other subsidiaries, Allyon Financial Advisors LLC and Allyon Real Estate Solutions LLC.
 

Digg icon reddit icon Stumbleupon icon
Contact Editor Latest News

Comments

Please Login/Register to post comments.

No comments have been added or approved.

On the MHT blog now

Bill Gates, Ray Ozzie, Microsoft execs patent 'personal data mining'

By Todd Bishop TechFlash Bill Gates, Ray Ozzie and a bunch of other heavy-hitters from Microsoft are named as inventors on a newly issued patent for a "personal data mining" system that would analyze information and make recommendations with the goal of aiding a person's decisions and improving quality of life. The patent was issued this week, based on a September 2006 patent application. I...

Read More

Boston University - MS MBA
Most Popular Stories
EmailedViewed
Stay Informed
Check which newsletter you'd like to receive.
TechFlash (Daily)
FinanceFlash (Daily)
BioFlash (Daily)
GreenFlash (Weekly)
Startup Report (Weekly)
Breaking news, MHT events, local announcements
RSS feeds
Your email:

Affiliate publications: ACBJ.com, Boston Business Journal, Bizjournals.com, Portfolio.com, Wired.com

Web Site Developed by Neptune Web, Inc.

Use of, registration on, this site constitutes acceptance of our User Agreement. Please read our Privacy Policy (updated) A publishing partner with Portfolio